Albert Bourla, CEO of Pfizer and the team "made this very difficult decision" to produce a product with mRNA technology. But when the time came, he delayed because he didn't want to "cut the line".
He first ridiculed anyone that might hesitate taking it in September 2020. Then when the time came in December that same year, he didn't want to "cut the line". Finally the truth drops in March '22 that "the mRNA was a technology that we had less experience [with]".
8 Sept 2020 - "Their decision [will effect] the lives of others [and] if they don't vaccinate they will become the weak link that will allow this virus to replicate"
14 Dec 2020: Doesn't want to "cut the line".
15 Dec 2020: Doesn't want to "cut the cue".
March 2022:"The mRNA was the technology that we had less experience [with and] mRNA was a technology that never delivered a single product".
Was Pfizer's experience with mRNA the reason he was "hesitant" given its experimental nature?
Albert Bourla, CEO of Pfizer and the team "made this very difficult decision" to produce a product with mRNA technology. But when the time came, he delayed because he didn't want to "cut the line".
He first ridiculed anyone that might hesitate taking it in September 2020. Then when the time came in December that same year, he didn't want to "cut the line". Finally the truth drops in March '22 that "the mRNA was a technology that we had less experience [with]".
8 Sept 2020 - "Their decision [will effect] the lives of others [and] if they don't vaccinate they will become the weak link that will allow this virus to replicate"
14 Dec 2020: Doesn't want to "cut the line".
15 Dec 2020: Doesn't want to "cut the cue".
March 2022:"The mRNA was the technology that we had less experience [with and] mRNA was a technology that never delivered a single product".
https://x.com/Humanspective/status/1776866639960764665